Comprehensive Chromosome Screening 

 
When it comes to assisted reproductive technologies (IVF), the medical experts at Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ’s Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy. This advanced embryo selection technique will not only prevent specific conditions such as Down Syndrome, but also dramatically reduce miscarriage rates and reduce the need to transfer multiple embryos to achieve conception. The ultimate reproductive medicine goal of “one embryo, one healthy baby” is now one large step closer to fruition.
RMANJ Monitoring Schedule
 

Click Here to View the RMANJ Monitoring Schedule for Each Location.